Advances in fetal gene therapy

Perinatology

Volumn 8, Issue 6, 2006, Pages 249-262

  Surbek, Daniel ^a   Schoeberlein, Andreina ^a   Portmann, Bettina ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; FIBRONECTIN; FLT3 LIGAND; GENE PRODUCT; LENTIVIRUS VECTOR; LIPOSOME; PARVOVIRUS VECTOR; PLASMID VECTOR; RETROVIRUS VECTOR; THROMBOPOIETIN; VIRUS VECTOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE SEVERITY; ENGRAFTMENT; GENE CONSTRUCT; GENE THERAPY; GENE VECTOR; GENETIC DISORDER; GENETIC MANIPULATION; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMAN; IMMUNITY; IMMUNOCOMPETENCE; IMMUNOLOGICAL TOLERANCE; LEUKEMOID REACTION; LYMPHATIC SYSTEM DISEASE; MEDICAL ETHICS; MORBIDITY; NONHUMAN; PATIENT SAFETY; PREGNANCY; PRENATAL CARE; PRENATAL DIAGNOSIS; REVIEW; TREATMENT OUTCOME;

EID: 34247872914     PISSN: 09722408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (136)

1. Abonour R, Williams DA, Einhorn L, Hall KM, Chen J, Coffman J, Traycoff CM, Bank A, Kato I, Ward M, Williams SD, Hromas R, Robertson MJ, Smith FO, Woo D, Mills B, Srour EF, Cornetta K. Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat Med 2000; 6: 652-8
2. Akkina RK, Walton RM, Chen ML, Li QX, Planelles V, Chen IS. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type-1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J Virol 1996; 70: 2581-5
3. Allay JA, Persons DA, Galipeau J, Riberdy JM, Ashmun RA, Blakley RL, Sorrentino BP. In vivo selection of retrovirally transduiced hematopoietic stem cells. Nat Med 1998; 4: 1136-43
4. Almeida-Porada G, Flake AW, Glimp HA, Zanjani ED. Cotransplantation of stroma results in enhancement and early expression of donor hematopoietic stem cells in utero. Exp Hematol t999; 27: 1569-75
5. Almeida-Porada G, Porada CD, Tran N, Zanjani ED. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood 2000; 95: 3620-3627
6. Anderson WF. Human gene therapy. Nature 1998; 392 (Supp): 25-30
7. Archer DR, Turner CW, Yeager AM, Fleming WH. Sustained multilineage engraftment of allogeneic hematopoietic stem cells in NOD/SCID mice after in utero transplantation. Blood 1997; 90: 3222-9
8. Archer DR, Hester LE, Gu Y, Fleming WH, Yeager AM, Hsu LL. Successful in utero engraftment of allogeneic hematopoietic cells in murine b-thalassemia. Blood 1998; 92: 267a
9. Baumgartner TL, Baumgartner BJ, Hudon L, Moise KJ. Ultrasonographically guided direct gene transfer in utero: successful induction of beta-galactosidase in a rabbit model. Am J Obstet Gynecol 1999; 181: 848-52
10. Bestor TH. Gene silencing as a threat to the success of gene therapy. J Clin Invest 2000; 105: 409-411
11. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 1998; 4: 1038-45
12. Billings PR. In utero gene therapy. The case against. Nat Med 1999; 5: 255-7
13. Blau CA, Stamatoyannopoulos G. Preemptive therapy for genetic disease. Nat Med 1996; 2: 161-2
14. Blau H, Khavari P. Gene therapy: Progress, problems, prospects. Nat Med 1997; 3: 612-3
15. Blaese RM, Culver KW, Miller AD et al. Tlymphocyte-directed gene therapy for ADA-SCID: initial results after 4 years. Science 1995; 270: 475-80
16. Blazar BR, Taylor PA, McElmurry R, Tian L, Panoskaltsis-Mortari A, Lam S, Lees C, Waldschmidt T, Vallera DA. Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via in utero or postnatal transfer. Blood 1998; 92: 3949-59
17. Blomer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH. Highly efficient and sustained gene transfer in adult neurons with a lentiviral vector. J Virol 1997; 71: 6641-9
18. Bordignon C, Notarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Mazzolari E, Maggioni D, Rossi C, Servida P, Ugazio AG, Mavilio F. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 1995; 270: 470-5
19. Brenner M. Gene transfer to hematopoietic cells. N Engl J Med 1996; 335: 337-9
20. Buckley RH, Schiff SE, Schiff RI, Markert ML, Williams LW, Roberts JL, Myers LA, Ward FE. Hematopoietic stem cell transplantation for the treatment of severe combined immunodeficiency syndrome. N Engl J Med 1999; 340: 508-16
21. Buckley RH. Gene therapy for human SCID: dreams become reality. Nat Med 2000; 6: 623-4
22. Bunting KD, Sangster MY, lhle JN, Sorrentino BP. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer. Nat Med 1998; 4: 58-64.
23. Burns JC, Friedmann T, Driever V, Burrascano M, Yii JK. Vesicular stomatitis virus G protein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A 1993; 90: 8033-7
24. Caplan AL, Wilson JM. The ethical challanges of in utero gene therapy. Nat Gene 2000; 24: 107
25. Carrier E, Hae T, Busch MP, Cowan MJ. Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoiefic stem cells. Blood 1995; 86: 4681-90
26. Case SS, Price MA, Jordan CT, Yu XJ, Wang L, Bauer G, Haas DL, Xu D, Stripecke R, Naldini L, Kohn DB, Crooks GM. Stable transduction of quiescent CD34+CD38- human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci U S A 1999; 96: 2988-93
27. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fisher A. Gene therapy of human severe combined immunodeficiency (SCID)-XI disease. Science 2000; 288: 669-672
28. Cavazzana-Calvo M et al. Ann Rev Med 2005
29. Chan V, Lau K, Sin SY, Cheung M-C, Kan YW. Diagnosis of spinal muscular atrophy from fetal normoblasts in maternal blood. Lancet 1998; 352: 1196-8
30. Cheung MC, Goldberg JD, Kan YW. Prenatal diagnosis of sickle cell anaemia and thalassaemia ba analysis of fetal cells in maternal blood. Nat Genet 1996; 14: 264-8
31. Clapp DW, Freie B, Lee W-H, Zhang Y-Y. Molecular evidence that in-situ transduced fetal liver hematopoietic stem/progenitor cells give rise to medullary hematopoiesis in adult rats. Blood 1995; 86: 2113-22
32. Conneally E, Eaves CJ, Humphries RK. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood 1998; 91: 3487-93
33. Coutelle C, Douar A-M, Colledge WH, Froster U. The challenge of fetal gene therapy. Nat Med 1995; 1: 864-6
34. Coutelle C, Themis M, Waddington SM, Buckley SMK, Gregory LG, Nivsarkar MS, David AL, Peebles D, Weisz B, Rodeck C. Gene Therapy Progress and Prospects: Fetal gene therapy - first proofs of concept - some adverse effects. Gene Ther 2005; 12; 1601-7
35. David AL, Peebles D, Gregory L, Themis M, Cook T, Miah M, Coutelle C, Kiserud T & Rodeck CH. Ultrasound-guided injection of the trachea in fetal sheep: a novel percutaneous technique to target the fetal airways in utero. Fet Diagn Ther 2003; 18: 385-90
36. Dejneka NS et al. In utero gene therapy rescues vision in a murine model of congenital blindness. Mol Ther 2004; 9: 182-8
37. Douar A-M, Themis M, Coutelle C. Fetal somatic gene therapy. Mol Hum Reprod 1996; 2: 633-41
38. Douglas J, Kelly P, Evans JT, Garcia JV. Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectors. Hum Gene Ther 1999; 10: 935-45
39. Ektherae D, Crombleholme T, Karson E, Harrison MR, Anderson WF, Zanjani ED. RetTovirai vector-mediated transfer of the bacterial neomycin resistance gene into fetal and adult sheep and human hematopoietic progenitors in vitro. Blood 1990; 75: 365-9
40. Flake AW, Roncarolo MG, Puck JM, Almeida-Porada G, Evans MI, Johnson MP, Abella EM, Harrison DD, Zanjani ED. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 1996; 335: 1806-10
41. Flake AW, Zanjani ED. In utero hematopoietic stem cell transplantation. A status report. JAMA 1997; 278: 932-7
42. Flake AW, Zanjani ED. In utero hematopoietic stem cell transplantation: ontogenetic opportunities and biologic barriers. Blood 1999; 94: 2179-91
43. Fletcher JC, Richter G. Human fetal gene therapy: moral and ethical questions. Hum Gene Ther 1996; 7: 1605-14
44. Geiger H, Sick S, Bonifer C, Miffler AM. Cell 1998; 93: 1055-65
45. Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G, Grupp SA, Sieff CA, Mulligan RC, Johnson RP. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 1997; 1337-45.
46. Güenechea G, Segovia JC, Albella B, Lamana M, Ramirez M, Regidor C, Fernández MN, Bueren JA. Delayed engraftment of nonobese diabetic/ severe combined immunodeficient mice transpanted with ex vivo-expanded human CD34+ cord blood cells. Blood 1999; 93: 1097-1105
47. Hacein-Bey S et al. Science 2003a; 302: 415-9
48. Hacein-Bey S et al. N Engl J Med 2003b; 348: 255-6
49. Hahn S, Sant R, Holzgreve W. Fetal cells in maternal blood: current and future perspectives. Mol Hum Reprod 1998; 4: 101-7
50. Harrington JJ, Van Bokkelen G, Mays RW, Gustashaw K, Willard HF. Formation of de novo centromeres and construction of first-generation human artificial microchromosomes. Nat Gene 1997; 15: 345-55
51. Hayashi SI, Morishita R, Aoki M, Moriguchi A, Kida I, Nakajima M, Kaneda Y, Higaki J, Ogihara T. In vivo gene transfer of gene and oligo deoxynucleotides into skin of fetal rats by incubation in amniotic fluid. Gene Ther 1996; 3: 878-85
52. Hayward A. Ambruso D, Battaglia F et al. Microchimerism and tolerance following intrauterine transplantation and transfusion for a-thalassemia-1. Fetal Diagn Ther 1998; 13: 8-14
53. Herzog RW, Yang EY, Couto LB, Hagstrom JN, Elwell D, Fields PA, Burton M, Bellinger DA, Read MS, Brinkhous KM, Podsakoff GM, Nichols TC, Kurtzman GJ, High KA. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 1999; 5: 56-63
54. Holzgreve W. Will ultrasound-screening and ultrasound-guided procedures be replaced by non-invasive techniques for the diagnosis of fetal chromosomal anomalies? Ultrasound Obstet Gynecol 1997; 9: 217-9
55. Holzinger A, Trapnell BC, Weaver TE, Whittset JA, Iwamoto HS. Intraamniotic administration of an adenoviral vector for gene transfer to fetal sheep and mouse tissues. Pediatr Res 1995; 38: 844-50
56. Issaragrisil S, Visuthisakchai S, Suvatte V, Tanphaichitr VS, Chandanayingyong D, Schreiner T, Kanokpongsakdi S, Siritanaratkul N, Piankijagum A. Brief report:Tmnsplantation of cord-blood stem cells into a patient with severe thalassemia. N Engl J Med 1995; 332: 367-9
57. Jimenez DF, Lee CI, O'Shea CE, Kohn DB, Tarantal AF. HIV-1 -derived lentiviral vectors and fetal route of administration on transgene biodistribution and expression in rhesus monkeys. Gene Ther 2005; 12: 821-30
58. Kafri T, Blomer U, Peterson DA, Gage FH, Verma IM. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 1997; 17: 314-7
59. Kalberer CP, Pawliuk R, Imren S, Bachelot T, Takekoshi KJ, Fabry M, Eaves CJ, London IM, Humphries RK, Leboulch P. Preselection of retrovirally transduced bone marrow avoids subsequent stem cell gene silencing and age-dependent extinction of expression of human beta-globin in engrafted mice. Proc Natl Acad Sci U S A 2000; 97: 5411-5
60. Kantoff PW, Flake AW, Eglitis MA, Scharf S, Bond S, Gilboa E, Erlich H, Hanison MR, Zanjani ED, Anderson WF. In utero gene transfer and expression: a sheep transplantation model. Blood 1989; 73: 1066-73
61. King D, Shakespeare T, Nicholson R, Clarke A, McLean S. Risks inherent in fetal gene therapy. Nature 1999; 397: 383
62. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, et al. Engraftment of gene-modified umbilical cord blood cells in neonates with amino-deaminase deficiency. Nat Med 1995; 1: 1017-23
63. Kohn DB, Hershfield MS, Carbonaro D, Shigeoka A, Brooks J, Smogorzewska EM, Barsky LW, Chan R, Burotto F, Annett G, Nolta JA, Crooks G, Kapoor N, Elder M, Wara D, Bowen T, Madsen E, Snyer FF, Bastian J, Muul L, Blaese RM, Weinberg K, Parkman R. T lymhpocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat Med 1998; 4: 775-80
64. Krivit W, Shapiro EG, Peters C, Wagner JE, Cornu G, Kurtzberg J, Wenger D, Kolodny EH, Vanier MT, Loes DJ, Dusenbery K, Lockman LA. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med 1998; 338: 1119-26
65. Larsen JE, Morrow SL, Happel L, Sharp JF, Cohen JC. Reversal of cystic fibrosis phenotype in mice by gene therapy in utero. Lancet 1997; 349: 619-20
66. Lee CC et al. Fetal gene transfer using lentiviral vectors and the potential for germ cell transduction in rhesus monkeys (Macaca mulatta). Hum Gene Ther 2005; 16: 417-425
67. Lipshutz GS, Sarkar R, Flebbe-Rehwaldt L, Kazazian H, Gaensler KML. Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero. Proc Natl Acad Sci U S A 1999; 96: 13324-9
68. Lucarelli G, Clift RA, Galimberti M, Angelucci E, Giardini C, Baronciani D, Polchi P, Andreani M, Gaziev D, Erer B, Ciaroni A, D'Adamo F, Albertini F, Muretto P. Bone marrow transplantation in adult thalassemic patients. Blood 1999; 93: 1164-7
69. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C, Politi P, Durazzi SMT, Muretto P, Albertini F. Bone marrow transplantation in patients with thalassemia. N Engl J Med 1990; 322: 417-21
70. Luther-Wyrsch A, Costello E, Thali M, Buetti E, Nissen C, Surbek D, Holzgreve W, Gratwohl A, Tichelli A, Wodnar-Filipowicz A. Stable transduction with lentiviral vectors and amplification of immature hematopoietic progenitors from cord blood of preterm human fetuses. Hum Gene Ther 2001; 12: 377-89
71. Lutzko C, Kruth S, Abrams-Ogg ACG, Lau K, Li L, Clark BR, Ruedy C, Nanji S, Foster R, Kohn D, Shull R, Dubé ID. Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine a-L-iduronidase deficiency. Blood 1999a; 93: 1895-905
72. Lutzko C, Omori F, Abrams-Ogg AC, Shull R, Li L, Ruedy C, Nanji S, Gartley C, Dobson H, Foster R, Kruth S, Dube ID. Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease. Hum Gene Ther 1999b; 10: 1521-32
73. Manno CS, Chew AJ, Hutchison S, Larson PJ, Herzog RW, Arruda VR, Tai SJ, Ragni MV, Thompson A, Ozelo M, Couto LB, Leonard DG, Johnson FA, McClelland A, Scallan C, Skarsgard E, Flake AW, Kay MA, High KA & Glader B. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 2003; 101, 2963-2972.
74. Marandin A, Dubart A, Pflumio F, Cosset F-L, Cordette V, Chapel-Fernandes S, Coulombel L, Vainchenker W, Louache F. Retrovirus-mediated gene transfer into human CD34+38low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo. Hum Gene Ther 1998; 9: 1497-511
75. Mason CAE, Bigras J-L, O'Blenes SB, Zhou B, McIntyre B, Nakamura N, Kaneda Y, Rabinovitch M. Gene transfer in utero biologically engineers a patent ductud arteriosus ini lambs by arresting fibronectin-dependent neointimal formation. Nat Med 1999; 5: 176-82
76. May C, Rivella S, Callegari J, Heller G; Gaensler KM, Luzzato L, Sadelain M. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature 2000; 406: 82-6
77. Milner R, Shaaban A, Kim HB,Fichter C, Flake AW. Natural killer cells do not mediate allograft rejection after in utero hematopoietic stem cell transplantation. Blood 1998a; 92: 288b
78. Milner R, Shaaban AF, Kim HB, Fichter C, Scully M, Asakura T, Flake AW. Long term high level expression of donor hemoglobin after in utero HSC transplantation in thalassemic knockout mice - selective advantage for donor red cells. Blood 1998b; 92: 696a
79. Miyasaka M, Morris B. The ontogeny of the lymphoid system and immune responsiveness in sheep. Prog Vet Microbiol Immun 1988; 4: 21-55
80. Miyoshi H, Takahashi M, Gage FH, Verma IM. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci U S A 1997, 94: 10319-23
81. Miyoshi H, Smith KA, Mosier DE, Verma IM, Torbett BE. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 1999; 283: 682-6
82. Mychaliska GB, Rice HE, Tarantal AF et al. In utero hematopoietic stem cell transplants prolong survival of postnatal kidney transplants in monkeys. J Pediatr Surg 1997; 32: 976-81
83. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-7
84. Office of Recombinant DNA Activities, National Institutes of Health (NIH), July 31, 1998
85. Omori F, Lutzko C, Abrams-Ogg A, Lau K, Gartley C, Dobson H, Nanji S, Ruedy C, Singaraja R, Li L, Stewart AK, Kruth S, Dube ID. Adoptive transfer of genetically modified human hematopoietic stem cells into preimmune canine fetuses. Exp Hematol 1999: 27: 242-9
86. Peebles D et al.Widespread and efficient marker gene expression in the airway epithelia of fetal sheep after minimally invasive tracheal application of recombinant adenovirus in utero. Gene Therapy 2004; 11: 70-8
87. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J, Fagioli F, Berger M,Aglietta M. Extensive Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997; 89: 2644-53
88. Pollok KE, Hanenberg H, Noblitt TW, Schroeder W, Kato I, Emanuel D, Williams D. High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments. J Virol 1998; 72: 4882-92
89. Porada CD, Tran N, Eglitis M, Moen RC, Troutman L, Flake AW, Zhao Y, Anderson WF, Zanjani ED. In utero gene therapy: transfer and longterm expression of the bacterial neo-r gene in sheep after direct injection of retroviral vectors into the preimmune fetus. Hum Gene Ther 1998; 9: 1571-85
90. Portmann-Lanz B, Schoeberlein A, Huber A, Sager R, Malek A, Holzgreve W, Surbek DV. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol 2006;194: 664-73
91. Qin L, Ding Y, Pahud DR, Chang E, Imperiale MJ, Bromberg JS: Pronnotor attenuation in gene therapy: Interferon-g and tumor necrosis factor-a inhibit transgene expression. Hum Gene Ther 1997;6: 1039
92. Ramsay G. DNA chips: state of the art. Nat Biotechnol 1998; 16: 40-4
93. Reiser J, Harmison G, Kluepfel-Stahl S, Brady RO, Karlsson S, Schubert M. Transduction of nondividing cells using pseudotyped defective high-titer HIV type1 particles. Proc Natl Acad Sci U S A 1996; 93: 15266-71
94. Rucker M et al. Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: Pompe disease. Development 2004; 131: 3007-19
95. Schachtner S, Buck C, Bergelson J, Baldwin H. Temporally regulated expression patterns following in utero adenovirus-mediated gene transfer. Gene Ther 1999; 6: 1249-57
96. Schilz AJ, Brouns G, Knöss H, Ottmann OG, Hoelzer D, Fauser AA, Thrasher AJ, Grez M. High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditions. Blood 1998; 92: 3163-71
97. Schneider H, Coutelle C. In utero gene therapy - The case for. Nat Med 1999; 5: 256-257.
98. Schoeberlein A, Schatt S, Troeger C, Surbek D, Holzgreve W, Hahn S. Engraftment kinetics of human cord blood and murine fetal liver stem cells following in utero transplantation into irrinnimodeficient mice. Stem Cells Dev 2004a; 13: 677-84
99. Schoeberlein A, Holzgreve W, Dudler L, Hahn S, Surbek DV. In utero transplantation of autologous and allogeneic fetal liver stem cells in ovine fetuses. Am J Obstet Gynecol 2004b; 191: 1030-6
100. Sekhon HS, Larson JE: In utero gene transfer into the pulmonary epithelium. Nat Med 1995; 1: 1201-3
101. Senut M-C, Suhr S, Gage FH. Gene transfer to the rodent placenta in situ. A new strategy fordelivering gene products to the fetus. J Clin Invest 1998; 101: 1565-71
102. Seppen J et al. Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer. Mol Ther 2003; 8: 593-9
103. Shields LE, Bryant EM, Easterling TR, Andrews RG. Fetal liver cell transplantation for the creation of lymphohematopoietic chimerism in fetal baboons. Am J Obstet Gynecol 1995; 173: 1157-60
104. Snyder RO, Miao C, Meuse L, Tubb J, Donahue BA, Lin H-F, Stafford DW, Patel S, Thompson AR, Nichols TN, Read MS, Bellinger DA, Brinkhous KM, Kay MA. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med 1999; 5: 64-70
105. Surbek DV, Gratwohl A, Holzgreve W. In utero hematopoietic stem cell transfer: current status and future strategies. Eur J Obstet Gynecol Reprod Biol 1999; 85: 109-15
106. Surbek DV, Tercanli S, Holzgreve W. Transabdominal first trimester embryofetoscopy as potential approach to early in utero stem cell transplantation and gene therapy. Ultrasound Obstet Gynecol 2000; 15: 302-7
107. Surbek DV, Holzgreve W, Nicolaides KH. Hematopoietic stem cell transplantation and gene therapy in the fetus: Ready for clinical use? Hum Rel2rod Update 2001: 7: 85-91
108. Surbek DV, Young A, Danzer E, Schoeberlein A, Holzgreve W. Ultrasound-guided stem cell sampling from the early ovine fetus for prenatal ex-vivo gene therapy. Am J Obstet Gynecol 2002; 187: 960-3
109. Sutton RE, Wu HTM, Rigg R, Böhnlein E, Brown P. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoiefic stem cells. J Virol 1998; 72: 5781-8
110. Tavassoli M. Embryonic and fetal hematopoiesis. Blood Cells 1991; 17: 269-81
111. Tavian M, Coulombel L, Luton D, San Clemente H, Dieterien-Lièvre F, Péault B. Aorta-associated CD34+ hematopoietic cells in the early human embryo. Blood 1996; 87: 67-72
112. Themis M, Schneider H, Kiserud T, Cook T, Adebakin S, Jezzard S, Forbes S, Hanson M, Pavirani A, Rodeck C, Coutelle C. Successful expression of beta-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultrasound-guided percutaneous adenovirus vector administration into the umbilical vein. Gene Ther 1999; 6: 1239-48
113. Themis M et al. Oncogenesis following delivery of a non-primate lentiviral gene therapy vector to fetal mice. Mol Ther 2005; 12: 257-66
114. Tran ND, Porada CD, Zhao Y, Almeida-Porada G, Anderson WF, Zanjani ED. In utero transfer and expression of exogenous genes in sheep. Exp Hematol 2000; 28: 17-30
115. Tsukamoto M, Ochiya T, Yoshida S, Sugimura T, Terada M. Gene transfer and expression in progeny after intravenous DNA injection into pregnant mice. Nat Gene 1995; 9: 243-8
116. Turner CW, Archer DR, Wong J, Yeager AM, Fleming WH. In utero transplantation of human fetal haemopoietic cells in NOD/SCID mice. Br J Haematol 1998; 103: 326-34
117. Uchida N, Sutton RE, Friera AM, He D, Reitsma MJ, Chang WC, Veres G, Scollay R, Weissmann IL. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc Natl Acad Sci U S A 1998; 95: 11939-44
118. Van Hennik PB, Verstegen MMA, Bierhuizen MFA, Limon A, Wognum AW, Cancelas JA, Barquinero J, Ploemacher RE, Wagemaker G. Highly efficient transduction of the green fluorescent protein gene in human umbilical cord blood stem cells capable of cobblestone formation in long-term cultures and multilineage engraftment of immunodeficient mice. Blood 1998; 92: 4013-22
119. Verma IM, Somia N. Gene therapy - promises, problems and prospects. Nature 1997; 389: 239-42
120. Vincent MC, Trapnell BC, Baughman RP, Wert SE, Whitsett JA, Iwamoto HS. Adenovirus-mcdiated gene transfer to the respiratory tract of fetal sheep in utero. Hum Gene Ther 1995; 6: 1019-28
121. Waddington S et al. In utem gene transfer of human factor IX to fetal mice can induce tolerance of the exogenous clotting factor. Blood 2003; 101: 1359-66
122. Waddington S et al. Permanent phenotypic correction of haemophilia B in immunocompetent mice by prenatal gene therapy. Blood 2004; 104: 2714-21
123. Wang G, Williamson R, Mueller G, Thomas P, Davidson BL, McCray PB: Ultrasound-guided gene transfer to hepatocytes in utero. Fetal Diagn Ther 1998; 13: 197-205
124. Weichhold FF, Zella D, Barabitskaja O, Maciejewski JP, Dunn DE, Sloand EM, Young NS. Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most primitive human hematopoietic stem cells as assessed in longterm bone marrow cultures. Blood 1998; 91: 907-15
125. Wengler GS, Lanfranchi A, Frusca T, Verardi R, Neva A, Brugnoni D, Giliani S, Fiorini M, Melia P, Guandalini F, Mazzolari E, Pecorelli S, Notarangelo LD, Porta F, Ugazio AG. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe immunodeficiency (SCIDXI). Lancet 1996; 348: 1484-7
126. Westgren M, Ringden O, Eik-Nes S et al. Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies. Transplantation 1996; 61: 1176-9
127. Winkler A, Kiem H-P, Shields L, Sun Q-H, Andrews RG. Gene transfer into fetal baboon hematopoietic progenitor cells. Hum Gene Ther 1999; 10: 667-77
128. Woo YJ, Raju GP, Swain JL, Richmond ME, Gardner TJ, Balice-Gordon RJ. In utero cardiac gene transfer via intraplacental delivery of recombinant adenovirus. Circulation 1997; 96: 3561-9
129. Wu Y, Liu J, Woo S, Finegold MJ, Brandt ML. Prenatal orogastric gene delivery results in transduction of the small bowel in the fetal rabbit. Fetal Diagn Ther 1999; 14: 323-7
130. Wyrsch A, Dalle Carbonare V, Jansen W, Chklovskaia E, Nissen C, Surbek D, Holzgreve W, Tichelli A, Wodnar-Filipowicz A. Preterm umbilical cord blood is enriched in early hematopoietic progenitors with expansion properties equal to term cord blood progenitors. Exp Hematol 1999; 27: 1338-45
131. Ye X, Gao GP, Pabin C, Raper SE, Wilson JM. Evaluating the potential of germ line transmission after intravenous administration of recombinant adenovirus in the OH mouse. Hum Gene Ther 1998; 9: 2135-42
132. Zanjani ED, Anderson WF. Prospects for in utero human gene therapy. Science 1999; 285: 2084-8
133. Zanjani ED, FlakeAW, Rice H, Hedrick M, Tavassoli M. Long-term repopulating ability of xenogeneic transplanted human liver hematopoietic stem cells in sheep. J Clin Invest 1994; 93: 1051
134. Zanjani ED, Almeida-Porada G, Ascensao JL, MacKintosh FR, Flake AW. Transplantation of hematopoietic stem cells in utero. Stem Cells 1997; 15 (Suppl. 1): 79-93
135. Ziegler BL, Valtieri M, Porada GA, De Maria R, Muller R, Masella B, Gabbianelli M, Casella I, Pelosi E, Bock T, Zanjani ED, Peschle C. KDR receptor: a key marker defining hematopoietic stem cells. Science 1999; 285: 1553-8
136. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997; 15: 871-5